748605190	748605190	CD	B-NP	O
|	|	NN	I-NP	O
EH	EH	NN	I-NP	O
|	|	NN	I-NP	O
18522371	18522371	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9714692	9714692	CD	B-NP	O
|	|	CC	I-NP	O
10/21/2006	10/21/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/21/2006	10/21/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
Flanagin	Flanagin	NNP	B-NP	O
,	,	,	O	O
Kris	Kris	NNP	B-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
OUTPATIENT	OUTPATIENT	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Blaine	Blaine	NNP	B-NP	O
Allabaugh	Allabaugh	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Phone	Phone	NNP	I-NP	O
Number	Number	NNP	I-NP	O
577-102-2686	577-102-2686	CD	I-NP	O
DATE	DATE	NNP	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NNP	B-NP	O
:	:	:	O	O
4/20/07	4/20/07	CD	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Cellulitis	Cellulitis	NN	B-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
leg	leg	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Majeau	Majeau	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
74-year-old	74-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
surgical	surgical	JJ	I-NP	O
debridement	debridement	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
getting	get	VBG	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
felt	feel	VBD	B-VP	O
suddenly	suddenly	RB	B-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
wheezy	wheezy	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
called	call	VBD	B-VP	O
EMS	EMS	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
and	and	CC	I-NP	O
foot	foot	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
painful	painful	JJ	B-ADJP	O
and	and	CC	O	O
swollen	swell	VBN	B-VP	O
x2	x2	NN	B-NP	O
weeks	week	NNS	I-NP	O
with	with	IN	B-PP	O
redness	redness	NN	B-NP	O
tracking	track	VBG	B-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
coughs	cough	NNS	B-NP	O
or	or	CC	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
nebulizers	nebulizer	NNS	B-NP	O
,	,	,	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
,	,	,	O	O
benign	benign	JJ	B-NP	O
prostatic	prostatic	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Coumadin	Coumadin	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Azmacort	Azmacort	NN	B-NP	O
with	with	IN	B-PP	O
ADAP	ADAP	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mcg	mcg	NN	I-NP	I-protein
inhaled	inhale	VBD	B-VP	I-protein
3	3	CD	B-NP	I-protein
puffs	puff	NNS	I-NP	I-protein
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
puffs	puff	NNS	I-NP	I-protein
inhaled	inhale	VBD	B-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.	q.	NN	B-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
ferrous	ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
one	one	CD	B-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-NP	O
daily	daily	RB	I-NP	O
-LRB-	-LRB-	JJ	I-NP	O
patient	patient	NN	I-NP	O
not	not	RB	B-VP	O
taking	take	VBG	I-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NN	B-NP	B-protein
causes	cause	VBZ	B-VP	O
rash	rash	NN	B-NP	O
,	,	,	O	O
Bactrim	Bactrim	NNP	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
Cipro	Cipro	NN	B-NP	O
causing	cause	VBG	B-VP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
roommate	roommate	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
retired	retire	VBN	I-VP	O
,	,	,	O	O
worked	work	VBD	B-VP	O
in	in	IN	B-PP	O
advertising	advertising	NN	B-NP	O
for	for	IN	B-PP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
for	for	IN	B-PP	O
No	No	DT	B-NP	O
He	He	PRP	B-NP	B-DNA
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
smoked	smoke	VBD	B-VP	O
60	60	CD	B-NP	O
pack	pack	NN	I-NP	O
years	year	NNS	I-NP	O
and	and	CC	O	O
quit	quit	VB	B-VP	O
26	26	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
any	any	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
,	,	,	O	O
use	use	VBP	B-VP	O
any	any	DT	B-NP	O
IV	IV	CD	I-NP	O
drugs	drug	NNS	I-NP	O
or	or	CC	O	O
illicit	illicit	JJ	B-NP	O
substances	substance	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
living	live	VBG	I-NP	O
sister	sister	NN	I-NP	O
,	,	,	O	O
Werner	Werner	NNP	B-NP	O
Lieberman	Lieberman	NNP	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
cancer	cancer	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
his	his	PRP$	B-NP	O
healthcare	healthcare	NN	I-NP	O
proxy	proxy	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
phone	phone	NN	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
624-913-9792	624-913-9792	CD	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
96.5	96.5	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
85	85	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
98/36	98/36	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
22	22	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Generally	Generally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-ADJP	O
with	with	IN	B-PP	O
short	short	JJ	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
irregular	irregular	JJ	I-NP	O
,	,	,	I-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
his	his	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
jaw	jaw	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Obese	Obese	NN	B-NP	O
,	,	,	O	O
nontender	nontender	RB	B-ADVP	O
,	,	,	O	O
without	without	IN	B-PP	O
masses	mass	NNS	B-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
pitting	pitting	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
erythematous	erythematous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inguinal	inguinal	JJ	I-NP	O
crease	crease	NN	I-NP	O
with	with	IN	B-PP	O
weeping	weep	VBG	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
neurologically	neurologically	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
129	129	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.7	5.7	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
0.9-1	0.9-1	CD	I-NP	O
.3	.3	NN	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
.	.	.	O	O

Magnesium	Magnesium	NNP	B-NP	O
1.6	1.6	CD	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	O
2.8	2.8	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

First	First	JJ	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BNP	BNP	NN	I-NP	B-protein
of	of	IN	B-PP	O
127	127	CD	B-NP	O
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
is	be	VBZ	B-VP	O
28.5	28.5	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
34.7	34.7	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
189	189	CD	B-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
is	be	VBZ	B-VP	O
usually	usually	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
20s	20s	CD	I-NP	O
.	.	.	O	O

Differential	Differential	JJ	B-ADJP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
97	97	CD	B-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
and	and	CC	O	O
20	20	CD	B-NP	O
bands	band	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
82	82	CD	B-NP	O
,	,	,	O	O
Q-waves	Q-wave	NNS	B-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	O
and	and	CC	I-NP	O
V2	V2	NN	I-NP	O
without	without	IN	B-PP	O
ST	ST	JJ	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
voltage	voltage	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
T-wave	T-wave	NN	I-NP	O
was	be	VBD	B-VP	O
upright	upright	JJ	B-ADJP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
and	and	CC	I-NP	O
V3	V3	NN	I-NP	B-protein
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
in	in	IN	B-PP	O
11/26	11/26	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
pericardial	pericardial	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
which	which	WDT	B-NP	O
shows	show	VBZ	B-VP	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
and	and	CC	I-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	B-protein
bases	base	NNS	I-NP	I-protein
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NNP	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NNP	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Inskeep	Inskeep	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
74-year-old	74-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
requiring	require	VBG	B-VP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
severe	severe	JJ	B-ADJP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
surgical	surgical	JJ	I-NP	O
debridement	debridement	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
recurrent	recurrent	NN	I-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
pseudonormalization	pseudonormalization	NN	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
,	,	,	O	O
V3	V3	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	I-NP	O
Zocor	Zocor	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
CK	CK	NN	I-NP	B-protein
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
increasing	increase	VBG	I-VP	O
,	,	,	O	O
but	but	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
clinically	clinically	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-NP	O
suspicion	suspicion	NN	I-NP	O
for	for	IN	B-PP	O
necrotizing	necrotize	VBG	B-VP	O
fasciitis	fasciitis	NN	B-NP	O
or	or	CC	I-NP	O
myositis	myositis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
cardiac	cardiac	JJ	B-ADJP	O
in	in	IN	B-PP	O
origin	origin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
overloaded	overload	VBN	I-VP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
given	give	VBN	I-VP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tricuspid	tricuspid	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
enlarged	enlarge	VBN	I-VP	O
heart	heart	NN	B-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
1/3/06	1/3/06	CD	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
precordial	precordial	JJ	I-NP	O
fat-pad	fat-pad	NN	I-NP	O
without	without	IN	B-PP	O
effusion	effusion	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EF	EF	NN	I-NP	B-protein
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
PA	PA	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
35	35	CD	B-NP	O
+	+	SYM	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
IVC	IVC	NN	I-NP	B-protein
was	be	VBD	B-VP	O
nonpulsatile	nonpulsatile	JJ	B-ADJP	O
suggesting	suggest	VBG	B-VP	O
increased	increase	VBN	B-NP	O
RA	RA	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
at	at	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
bleeding	bleed	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
on	on	IN	B-PP	O
6/10/06	6/10/06	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
hematemesis	hematemesis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
3	3	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
Mallory-Weiss	Mallory-Weiss	JJ	I-NP	O
tear	tear	NN	I-NP	O
from	from	IN	B-PP	O
coughing	cough	VBG	B-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
stabilized	stabilize	VBD	B-VP	O
at	at	IN	B-PP	O
27	27	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
fibrinogen	fibrinogen	NN	I-NP	B-protein
D-dimer	D-dimer	NN	I-NP	I-protein
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
n.p.o.	n.p.o.	NN	B-NP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
four	four	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
FFP	FFP	NN	B-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

An	An	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
since	since	IN	B-SBAR	O
removed	remove	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
GI	GI	NNP	I-NP	O
Service	Service	NNP	I-NP	O
recommended	recommend	VBD	B-VP	O
an	an	DT	B-NP	O
IV	IV	CD	I-NP	O
proton	proton	NN	I-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/9/06	11/9/06	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
that	that	RB	B-ADVP	O
well	well	RB	I-ADVP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
hematocrits	hematocrit	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Respiratory	Respiratory	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
wheeziness	wheeziness	NN	B-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
DuoNebs	DuoNeb	NNS	B-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
wheeziness	wheeziness	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
recurrent	recurrent	JJ	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
debridement	debridement	NN	I-NP	O
in	in	IN	B-PP	O
11/26	11/26	CD	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
drawn	draw	VBN	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
6/7/06	6/7/06	CD	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
acinetobacter	acinetobacter	NN	B-NP	O
diphtheroids	diphtheroid	NNS	I-NP	O
.	.	.	O	O

Wound	Wound	JJ	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
showed	show	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
acinetobacter	acinetobacter	NN	I-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
streptococcus	streptococcus	NN	I-NP	O
group	group	NN	I-NP	O
G	G	NN	I-NP	O
corynebacterium	corynebacterium	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
grew	grow	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
MRSA	MRSA	NN	I-NP	O
,	,	,	O	O
corynebacterium	corynebacterium	NN	B-NP	O
and	and	CC	O	O
beta	beta	NN	B-NP	O
strep	strep	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
organisms	organism	NNS	I-NP	O
were	be	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
staph	staph	NN	I-NP	O
aureus	aureus	NN	I-NP	O
MRSA	MRSA	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-protein
culture	culture	NN	I-NP	I-protein
6/10/06	6/10/06	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	O
on	on	IN	B-PP	O
6/10/06	6/10/06	CD	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NN	I-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
1/3/06	1/3/06	CD	I-NP	O
showed	show	VBD	B-VP	O
Gram-negative	Gram-negative	JJ	B-NP	O
rods	rod	NNS	I-NP	O
.	.	.	O	O

Surgical	Surgical	NNP	B-NP	O
Service	Service	NNP	I-NP	O
recommended	recommend	VBD	B-VP	O
antibiotic	antibiotic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
started	start	VBD	B-VP	O
6/7/06	6/7/06	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	B-NP	I-protein
started	start	VBD	B-VP	I-protein
6/7/06	6/7/06	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
aztreonam	aztreonam	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
on	on	IN	B-PP	O
1/3/06	1/3/06	CD	B-NP	O
for	for	IN	B-PP	O
Acinetobacter	Acinetobacter	NNP	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
gentamicin	gentamicin	NN	B-NP	O
x1	x1	NN	I-NP	O
on	on	IN	B-PP	O
6/10/06	6/10/06	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
for	for	IN	B-PP	O
four	four	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
stop	stop	VB	I-VP	O
on	on	IN	B-PP	O
6/13/06	6/13/06	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
Flagyl	Flagyl	NN	B-NP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
-LRB-	-LRB-	NNP	B-NP	O
started	start	VBD	B-VP	O
8/27/06	8/27/06	CD	B-NP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
on	on	IN	B-PP	O
10/11/07	10/11/07	CD	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
C.	C.	NNP	I-NP	O
diff	diff	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
wound	wound	JJ	I-NP	O
culture	culture	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
is	be	VBZ	B-VP	O
polymicrobial	polymicrobial	JJ	B-ADJP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
the	the	DT	B-NP	O
erythema	erythema	NN	I-NP	O
spread	spread	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
becomes	become	VBZ	B-VP	O
febrile	febrile	JJ	B-ADJP	O
,	,	,	O	O
or	or	CC	O	O
his	his	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
become	become	VB	B-VP	O
more	more	JJR	B-NP	O
tender	tender	NN	I-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
threshold	threshold	NN	I-NP	O
for	for	IN	B-PP	O
noncontrast	noncontrast	JJ	B-NP	O
CT	CT	NN	I-NP	O
and	and	CC	O	O
surgical	surgical	JJ	B-NP	O
consultation	consultation	NN	I-NP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
Dopplers	Doppler	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
but	but	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
incomplete	incomplete	JJ	B-NP	O
visualization	visualization	NN	I-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	B-protein
left	left	JJ	I-NP	I-protein
leg	leg	NN	I-NP	I-protein
veins	vein	NNS	I-NP	I-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
baseline	baseline	NN	I-NP	I-protein
creatinine	creatinine	NN	I-NP	I-protein
0.9-1	0.9-1	CD	I-NP	I-protein
.1	.1	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
hyponatremia	hyponatremia	NN	B-NP	O
,	,	,	O	O
hyperkalemia	hyperkalemia	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
adrenal	adrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
but	but	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
random	random	JJ	I-NP	O
cortisol	cortisol	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
fractional	fractional	JJ	I-NP	O
excretion	excretion	NN	I-NP	O
of	of	IN	B-PP	O
urea	urea	NN	B-NP	O
was	be	VBD	B-VP	O
26	26	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
since	since	IN	I-VP	O
been	be	VBN	B-NP	O
volume	volume	NN	I-NP	O
resuscitated	resuscitate	VBN	B-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
responded	respond	VBD	B-VP	O
accordingly	accordingly	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
held	hold	VBN	I-VP	O
his	his	PRP$	B-NP	O
Lovenox	Lovenox	NNP	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
proton	proton	NN	I-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
DNR/DNI	DNR/DNI	NNP	B-NP	O
.	.	.	O	O

Pressors	Pressor	NNS	B-NP	O
are	be	VBP	B-VP	O
okay	okay	JJ	B-ADJP	O
.	.	.	O	O

Healthcare	Healthcare	NNP	B-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
Hal	Hal	NNP	B-NP	O
Feucht	Feucht	NNP	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
his	his	PRP$	B-NP	O
sister	sister	NN	I-NP	O
624-913-9792	624-913-9792	CD	I-NP	O
.	.	.	O	O

CONSULTS	CONSULTS	NNS	B-NP	O
:	:	:	O	O
GI	GI	NN	B-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Nagai	Nagai	NNP	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Furr	Furr	NNP	I-NP	O
.	.	.	O	O

Surgery	Surgery	NNP	B-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Myles	Myles	NNP	I-NP	O
Messel	Messel	NNP	I-NP	O
.	.	.	O	O

TO	TO	TO	B-PP	B-protein
DO	DO	NNP	B-NP	I-protein
:	:	:	O	I-protein
1	1	CD	B-NP	I-protein
.	.	.	O	O

Continue	Continue	IN	B-PP	O
IV	IV	CD	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
all	all	DT	B-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Resume	Resume	NNP	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
prophylactic	prophylactic	JJ	I-NP	O
Lovenox	Lovenox	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Have	Have	VB	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Have	Have	VB	B-VP	O
him	him	PRP	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
GI	GI	NNP	I-NP	O
Service	Service	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
fluid	fluid	JJ	B-ADJP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
low-cholesterol	low-cholesterol	NN	I-NP	O
,	,	,	O	O
low-fat	low-fat	JJ	B-ADJP	O
,	,	,	O	O
2	2	CD	B-NP	O
grams	gram	NNS	I-NP	O
sodium	sodium	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

ACTIVITY	ACTIVITY	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
should	should	MD	B-VP	O
elevate	elevate	VB	I-VP	O
his	his	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
with	with	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
sitting	sit	VBG	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Pending	Pending	NNP	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-2939367	4-2939367	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
CRABILL	CRABILL	NNP	B-NP	O
,	,	,	O	O
BERRY	BERRY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
Brislin	Brislin	NNP	B-NP	O
,	,	,	O	O
Wilber	Wilber	NNP	B-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8405694	8405694	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/15/06	7/15/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/15/06	7/15/06	CD	B-NP	O

